Dr. Anthony J. Langone, MD

Dr. Langone practices at Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center.

Dr. Langone's NPI, 1841387974, was assigned on October 9, 2006. Dr. Langone holds Tennessee license MD34174.

Dr. Langone's primary practice is Vanderbilt University Medical Center, at 1211 Medical Center Drive, Nashville, TN 37232 in Davidson County. The practice phone is (615) 322-3454.

Dr. Langone's primary practice is Vanderbilt University Medical Center in Nashville, Tennessee, part of Vanderbilt University Medical Center. Dr. Langone is also affiliated with Huntsville Hospital. The medical group on file is Vanderbilt University Medical Center. Dmand AI also links Dr. Langone to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Langone practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Langone's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Langone is licensed in Tennessee.

CMS data shows 1,384 Medicare services from Dr. Langone across 9 procedure codes in 2024, for 415 Medicare patients. Medicare paid $111,490 for them.

CMS counts 415 Medicare patients who saw Dr. Langone in 2024. The largest group is under 65, with 210 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 15% are also on Medicaid. Their average risk score is 4.44, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Langone's median patient age at 61, with 46% women.

In 2024, Dr. Langone wrote 4,792 Medicare Part D claims for 363 patients. 93% of them were for generic drugs. CMS names the drug for 4,358 of them, across 76 drugs with 11 or more claims each, at $198,445 in total drug cost. In 2023, CMS named 4,589 claims across 76 drugs.

Dr. Langone accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Langone as offering telehealth.

Dmand AI links 28 papers to Dr. Langone, published from 2012 to 2025. 2014 was the busiest year, with 3. The most frequent topics are Kidney Transplantation, Immunosuppressive Agents and Graft Rejection. Dr. Langone has published most often in Transpl Infect Dis. Dr. Langone's most frequent co-authors are Beatrice L. Concepcion, MD, Laurence Chan, MD and Rachel Forbes, MD.

Dmand AI links Dr. Langone to 1 clinical trial. 1 is still active or recruiting.

CMS Open Payments shows 42 general payments to Dr. Langone from 13 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 83% of the total. Veloxis Pharmaceuticals, Inc. paid the most, $16,556.